Skip to content

Clinical trials

Nasopharyngeal Neoplasms trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nasopharyngeal Neoplasms Country / region: Hong Kong Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20063
20101
20161
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong3
Novartis Pharmaceuticals2
Sanofi2
Cullinan Therapeutics Inc.1
Hoffmann-La Roche1
The University of Hong Kong1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nasopharyngeal Neoplasms10
Epstein-Barr Virus Infections3
Nasopharyngeal Carcinoma3
Recurrence2
Adenocarcinoma, Clear Cell1
Anus Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Ovarian Epithelial1
Carcinoma, Renal Cell1
Colonic Neoplasms1

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.